Ms. Michelle Lefler reports

AURORA CANNABIS ADVISES OF SECOND FALSE ARTICLE FROM INVESTING.COM

Aurora Cannabis Inc. has become aware of a second instance of misinformation posted on the Investing website.

On June 18, 2025, Aurora advised the market that an article posted on the Investing website incorrectly stated that Aurora had agreed to acquire New Zealand-based MedLeaf Therapeutics. Later in the day on June 18, 2025, a second article was posted on the Investing website that incorrectly states that Aurora has entered into a strategic partnership with MediPharm GmbH for the distribution of medical cannabis in Germany and other European Union markets.

The company categorically denies both Investing articles. Aurora has not entered into any such agreements, has had no discussions with MedLeaf Therapeutics or MediPharm with respect to any business combination transaction or strategic partnership, and has not made any statements or filed any information pertaining to any such transactions.

The erroneous articles posted on the Investing website state that they were generated "with the support of artificial intelligence" and reviewed by an editor. The company is launching an investigation into the genesis of these articles. In the meantime, Aurora confirms that it is not in possession of material non-public information and advises investors that the Investing website should not be considered a credible source of information regarding the company. Any information regarding material corporate transactions will be announced directly by the company to the market as soon as it is appropriate to do so.

About Aurora Cannabis Inc.

Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and New Zealand. Headquartered in Edmonton, Alta., Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co., as well as international brands Pedanios, Bidiol, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched.

We seek Safe Harbor.